COPD and Sleep Apnea Together: Overlap Syndrome

When chronic obstructive pulmonary disease and obstructive sleep apnea occur in the same person, the combination has its own name: overlap syndrome. It is not a separate disease, but it behaves worse than the arithmetic of two conditions suggests, and it is common enough that anyone with COPD who snores should know the term.

Why the combination is worse

COPD impairs gas exchange while you are awake. Apnea adds repeated collapse of the upper airway while you are asleep. The result is that overnight oxygen levels start from a lower baseline and then fall further with each obstructive event, which is a different and harder problem than either condition alone.

The mechanisms usually named are intermittent hypoxia, systemic inflammation and sympathetic activation — the same triad that drives cardiovascular risk in apnea generally, operating on lungs that already have reduced reserve.

That is coherent physiology and it is why overlap syndrome is treated as a higher-risk state in practice.

What the evidence actually quantifies, which is less than you would expect

A 2026 systematic review set out to compare the burden of cardiovascular comorbidity in people with COPD plus apnea against COPD alone — exactly the question a patient would ask.

Nineteen studies met inclusion. Most were cross-sectional or retrospective cohorts, all observational.

Its central finding is a gap rather than a number. Cardiovascular disease was reported as a baseline characteristic in nearly all the included studies — but none of them evaluated the prevalence of cardiovascular disease as a primary outcome.

Read that carefully, because it is unusual and important. Nineteen studies of a condition defined partly by its cardiovascular risk, and the cardiovascular risk was never the thing being measured. It was recorded in the table describing who the patients were.

So the honest position is: the physiological case for extra risk is strong, the clinical consensus treats it as real, and the literature has not yet produced the comparative figure. Anyone quoting you a precise multiple of risk for overlap syndrome is going beyond what has been measured.

Evidence tier 2. Mechanism well characterised, consensus consistent, comparative quantification largely absent. Newer work is moving toward phenotype-guided approaches rather than treating overlap as one entity, which is probably the right direction given how different two patients with the same label can be.

What it changes practically

Oxygen alone is not the answer for the apnea part. This is the most consequential point. Supplemental oxygen treats low oxygen; it does nothing to stop an airway collapsing. Someone with overlap syndrome on night-time oxygen can still be obstructing repeatedly, and the oxygen can mask the desaturations that would otherwise reveal it. Why oxygen is not a substitute for CPAP.

Positive airway pressure does more than one job here. It holds the upper airway open, and in people who also hypoventilate, bilevel pressure supports ventilation as well. This is one of the clearest indications for bilevel rather than fixed CPAP. CPAP, APAP and BiPAP compared.

Smoking status is the shared lever. It drives the COPD and worsens the snoring, and it is the one intervention that acts on both ends. Smoking and snoring.

Ask for the overnight oximetry or sleep study rather than assuming the COPD explains everything. This is the diagnostic trap: in someone with known lung disease, night-time breathlessness, morning headaches and daytime sleepiness get attributed to the COPD. They are also the apnea symptom list. Morning headaches and sleep apnea.

And no consumer product addresses any of this. Nasal strips, mouth tape and positional devices are not treatments for apnea, and they are certainly not treatments for COPD. If you have both, the pathway is respiratory and sleep medicine. What separates snoring from apnea, and what untreated apnea accumulates.